Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC071 (0.2% chlorhexidine digluconate) mouthwash for prevention of alveolar osteitis after third molar extraction
2014-004682-24Phase 4Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of chlorhexidine in alveolar osteitis (AO), sponsored by Pierre Fabre Laboratories. Primary endpoint: Occurrence of alveolar osteitis within 7 days. Started Mar 2015; status: completed.
02
Drugs
chlorhexidine
03
Conditions
alveolar osteitis (AO)
Beyond the preview
Go deeper on 2014-004682-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004682-24.